Maxwell Wealth Strategies’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$707K Sell
9,097
-1,165
-11% -$86.3K 0.29% 73
2024
Q3
$708K Buy
10,262
+329
+3% +$27K 0.3% 74
2024
Q2
$1.13M Buy
9,933
+108
+1% +$13.7K 0.55% 57
2024
Q1
$1.16M Buy
+9,825
New +$1.23M 0.59% 58

Other funds holding DXCM

Maxwell Wealth Strategies's DXCM Position: Q4 2024 in Review

Maxwell Wealth Strategies reduced its DexCom (DXCM) stake by 11% in Q4 2024, selling an estimated $86.3K and leaving 9,097 shares worth $707K. The position accounts for 0.29% of the portfolio, ranked #73.

Maxwell Wealth Strategies first reported a position in DXCM in Q1 2024 and has held it in 4 quarters since. The position peaked at $1.16M in Q1 2024. 950 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

  • Maxwell Wealth Strategies held 9,097 shares of DexCom worth $707K as of Q4 2024.
  • Maxwell Wealth Strategies sold 1,165 DexCom shares in Q4 2024, an estimated $86.3K.
  • DexCom made up 0.29% of Maxwell Wealth Strategies's portfolio in Q4 2024, its #73 holding.
  • Maxwell Wealth Strategies first reported a position in DexCom in Q1 2024 and has held it in 4 quarters since.
  • Maxwell Wealth Strategies's DexCom position peaked at $1.16M in Q1 2024.
  • 950 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on Maxwell Wealth Strategies's 13F filing for Q4 2024, filed 13 Feb 2025.